An early growth-hormone-releasing hexapeptide notable in research for a pronounced appetite-stimulating (hunger) effect alongside GH release.
Mechanism under study
Agonizes the ghrelin receptor to release GH and strongly stimulates appetite signaling, which is why it is frequently referenced in feeding and metabolism research.
Research-reported dosing
Research references commonly cite ~100–300 mcg per dose. Marked hunger is a commonly noted research effect. Not established for general human use.
Based on a standard 10 mg vial: with 2 mL bacteriostatic water = 5,000 mcg/mL (5 mg/mL); 1 unit ≈ 50 mcg.
A 200 mcg dose ≈ 4 units (50 mcg per unit).
Open this mix in the calculator →Source research-grade GHRP-6 ↗Dosing figures describe how this compound appears in the research literature and research-community references. They are not a recommendation for human use.
GHRP-6 FAQ
What is GHRP-6?
An early growth-hormone-releasing hexapeptide notable in research for a pronounced appetite-stimulating (hunger) effect alongside GH release.
What is the half-life of GHRP-6?
Approximately 15–60 minutes.
What is the research-reported dosing for GHRP-6?
Research references commonly cite ~100–300 mcg per dose. Marked hunger is a commonly noted research effect. Not established for general human use.
How is GHRP-6 reconstituted?
Based on a standard 10 mg vial: with 2 mL bacteriostatic water = 5,000 mcg/mL (5 mg/mL); 1 unit ≈ 50 mcg.
Is GHRP-6 FDA-approved?
No — GHRP-6 is not FDA-approved and is sold for laboratory research use only.
References
Related peptides
GHRP-2
Growth-hormone-releasing peptide (ghrelin-receptor agonist)
A potent growth-hormone-releasing peptide and ghrelin-receptor agonist studied for stimulating GH release; also investigated as a diagnostic test of pituitary GH reserve.
Ipamorelin
Ghrelin-receptor agonist (GH secretagogue)
A selective ghrelin-receptor agonist studied for stimulating growth-hormone release with comparatively little effect on cortisol or prolactin, making it a frequently referenced 'clean' secretagogue.
Hexarelin
Growth-hormone-releasing peptide (ghrelin-receptor agonist)
A potent synthetic GH-releasing hexapeptide, structurally related to GHRP-6, additionally studied for cardiovascular-tissue effects in preclinical models.